Editas Medicine, Inc. Business Finance Contracts & Agreements
12 Contracts & Agreements
- Stock Agreements (6 contracts)
- Underwriting Agreements (6)
- Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 28, 2024)
- Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 28, 2024)
- Underwriting Agreement, June 14, 2023, by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group, L.L.C (Filed With SEC on June 15, 2023)
- Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on May 14, 2021)
- Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (Filed With SEC on January 21, 2021)
- Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter (Filed With SEC on June 25, 2020)
- Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen (Filed With SEC on May 15, 2020)
- Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
- Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
- Underwriting Agreement, dated December 5, 2017, by and among Editas Medicine, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on December 7, 2017)
- 4,000,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on March 17, 2017)
- [ ] Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on January 25, 2016)
